National Institute of Mental Health (NIMH): Alzheimer Disease trials
The registry lists 14 Alzheimer Disease studies with National Institute of Mental Health (NIMH) as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 3Phase 4 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain DiseaseRecruitingNCT04396873Phase 1
- Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's DiseaseCompletedNCT00955422
- Development and Decline of Brain and Cognition Through the Life SpanCompletedNCT00880451
- P-glycoprotein Function in Brain DiseasesCompletedNCT00677885
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)TerminatedNCT00459693Not applicable
- PET Imaging of Brain Amyloid Using [11C]MeS-IMPYCompletedNCT00407576Phase 1
- The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's DiseaseCompletedNCT00046358Phase 4
- Brain Imaging in Alzheimer's DiseaseCompletedNCT00039702
- Evaluation of Age- and Alzheimer's Disease-Related Memory DisorderCompletedNCT00029120
- CATIE-Alzheimer's Disease TrialCompletedNCT00015548Not applicable
- Effects of an Anti-Inflammatory Drug in Alzheimer's DiseaseCompletedNCT00013650Phase 1
- The Effect of Acetylcholine on Memory and AttentionCompletedNCT00001977
- Brain Imaging in Elderly People and Individuals With Alzheimer's DiseaseCompletedNCT00001917
- The Evaluation and Follow-up of Individuals With Memory DisorderCompletedNCT00001480